Pulmonary pathology of acute respiratory distress syndrome - PubMed (original) (raw)
Review
Pulmonary pathology of acute respiratory distress syndrome
J F Tomashefski Jr. Clin Chest Med. 2000 Sep.
Abstract
Lung morphology in ARDS reflects the rapid evolution from interstitial and alveolar edema to end-stage fibrosis consequent to injury of the alveolocapillary unit. This morphologic progression, termed diffuse alveolar damage, has been subdivided into sequentially occurring exudative, proliferative, and fibrotic phases. Pulmonary lesions correlate with the phase of alveolar damage rather than its specific cause. The pathologic features are consistent with the effects of a host of injurious stimuli and the complex interaction of inflammatory mediators on alveolar epithelial and capillary endothelial cells. Although ARDS frequently culminates in "interstitial" fibrosis, the organization of intraluminal exudate dominates the histologic picture in the proliferative phase and establishes the framework for subsequent fibrous remodeling of the lung. Involvement of the pulmonary vasculature is an important aspect of ARDS, from the initial phase of edema to the terminal stage of intractable pulmonary hypertension. Vascular lesions include thrombotic, fibroproliferative, and obliterative changes that, like the parenchymal lesions, correlate with the temporal phase of DAD. Although ARDS is characterized by extensive bilateral lung involvement, alveolar damage can also affect the lung in a localized fashion. RAD is associated with the same clinical risk factors as DAD, suggesting that there is a spectrum in the extent of lung involvement and disease severity in patients at risk for ARDS. The factors that govern which patients will develop the fulminant syndrome are poorly understood. It must be re-emphasized that the lung is stereotyped in its response to injury and, consequently, descriptive, or even quantitative, studies of lung morphology can only provide clues regarding the initiating factors and pathogenetic mechanisms of ARDS. Progress in understanding the pathogenesis of ARDS and development of rational approaches to therapy will ultimately depend on careful clinical and experimental studies and the application of immunohistochemical and molecular biology techniques to unravel basic mechanisms of cellular injury and response.
Similar articles
- Pulmonary pathology of the adult respiratory distress syndrome.
Tomashefski JF Jr. Tomashefski JF Jr. Clin Chest Med. 1990 Dec;11(4):593-619. Clin Chest Med. 1990. PMID: 2268992 Review. - Morphometric differences in pulmonary lesions in primary and secondary ARDS. A preliminary study in autopsies.
Hoelz C, Negri EM, Lichtenfels AJ, Conceção GM, Barbas CS, Saldiva PH, Capelozzi VL. Hoelz C, et al. Pathol Res Pract. 2001;197(8):521-30. Pathol Res Pract. 2001. PMID: 11518044 - Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies.
Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errázuriz P, Martín-Pellicer A, Lorente JA, Frutos-Vivar F. Thille AW, et al. Lancet Respir Med. 2013 Jul;1(5):395-401. doi: 10.1016/S2213-2600(13)70053-5. Epub 2013 May 15. Lancet Respir Med. 2013. PMID: 24429204 - ARDS and diffuse alveolar damage: a pathologist's perspective.
Castro CY. Castro CY. Semin Thorac Cardiovasc Surg. 2006 Spring;18(1):13-9. doi: 10.1053/j.semtcvs.2006.02.001. Semin Thorac Cardiovasc Surg. 2006. PMID: 16766248 Review. - Lung parenchyma remodeling in acute respiratory distress syndrome.
Rocco PR, Dos Santos C, Pelosi P. Rocco PR, et al. Minerva Anestesiol. 2009 Dec;75(12):730-40. Minerva Anestesiol. 2009. PMID: 19940826 Review.
Cited by
- A Histological Analysis and Detection of Complement Regulatory Protein CD55 in SARS-CoV-2 Infected Lungs.
Silawal S, Gögele C, Pelikan P, Werner C, Levidou G, Mahato R, Schulze-Tanzil G. Silawal S, et al. Life (Basel). 2024 Aug 23;14(9):1058. doi: 10.3390/life14091058. Life (Basel). 2024. PMID: 39337843 Free PMC article. - TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment.
Alfaro E, Casitas R, Díaz-García E, García-Tovar S, Galera R, Torres-Vargas M, Fernández-Velilla M, López-Fernández C, Añón JM, Quintana-Díaz M, García-Río F, Cubillos-Zapata C. Alfaro E, et al. Front Immunol. 2024 Aug 29;15:1401015. doi: 10.3389/fimmu.2024.1401015. eCollection 2024. Front Immunol. 2024. PMID: 39281687 Free PMC article. - Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.
Lucà S, Pagliuca F, Perrotta F, Ronchi A, Mariniello DF, Natale G, Bianco A, Fiorelli A, Accardo M, Franco R. Lucà S, et al. Int J Mol Sci. 2024 Mar 23;25(7):3618. doi: 10.3390/ijms25073618. Int J Mol Sci. 2024. PMID: 38612431 Free PMC article. Review. - Efficacy of initial high- versus low-dose intravenous corticosteroid therapy in patients with acute exacerbation of idiopathic interstitial pneumonia: A nationwide observational study.
Awano N, Jo T, Izumo T, Inomata M, Morita K, Matsui H, Fushimi K, Urushiyama H, Nagase T, Yasunaga H. Awano N, et al. Ann Clin Epidemiol. 2022 Oct 26;5(2):37-47. doi: 10.37737/ace.23006. eCollection 2023. Ann Clin Epidemiol. 2022. PMID: 38505731 Free PMC article. - Prone Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review.
Spadaro S, Jimenez-Santana JD, La Rosa R, Spinazzola G, Argente Navarro P, Volta CA, Scaramuzzo G. Spadaro S, et al. J Clin Med. 2024 Jan 5;13(2):317. doi: 10.3390/jcm13020317. J Clin Med. 2024. PMID: 38256451 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources